BIOMIT Center for Molecular Immunology - CIM

Clinical trial: "Safety and effect of ior®EPOCIM in patients convalescing from SARS-CoV-2 infection with cardiovascular, renal and/or respiratory sequelae"

Wednesday, July 6, 2022

Author: CIM

Source: CIM

External Source: MINSAP

images/Content/noticias/99e48f5c-3b69-4d02-b044-37a9ef6fb193.png A study is being carried out to evaluate the safety and effect of the drug ior®EPOCIM (produced by the Center for Molecular Immunology), in the treatment of post-COVID-19 convalescent patients with cardiovascular, renal and respiratory sequelae. Cuban subjects of any sex, aged 19 or older, who have suffered from COVID 19 (confirmed by PCR) and who 2 or 3 months later and to date present manifestations such as: Chest pain, rhythm fast heartbeat; Shortness of breath (especially on exertion), cough, difficulty climbing a ladder or hill, difficulty walking long distances; Changes in urine (foamy or bloody urine, more or less urine than usual, or needing to get up at night to urinate), fatigue (feeling more tired and have less energy than usual), dry skin and itching, swelling of the hands or feet, bags around the eyes (especially in the morning), shortness of breath, lower back pain, high blood pressure, poor appetite or nausea and vomiting, difficulty concentrating, trouble concentrating sleep cramps at night. <br /> <br />Diagnosis of these sequelae will be confirmed by computerized axial tomography or other cardiovascular or respiratory function tests, as directed by the study physician. Pregnant or lactating women, or subjects with a history of thromboembolic disease in the last 3 to 6 months, or a history of serious chronic or life-limiting diseases, or who are receiving dialysis or hemodialysis treatment, or have received treatment with an investigational product in the last 6 months. Subjects with mental incapacity that prevents them from understanding the research, signing the participation consent document and complying with the treatment scheme and the evaluations provided for in the study may not be included either. <br /> <br />Two treatment groups will be formed. A group called the "control group" will receive treatment with only conventional therapy. This may include respiratory physiotherapy or other drugs that, according to the doctor's criteria, may be used to treat the cardiovascular, renal or respiratory sequelae under study. The other group called "study group", in addition to conventional therapy will receive 5 administrations of ior®EPOCIM. Subjects are assigned to one or another treatment group by personnel who are not involved in the research, so all subjects will have an equal chance of receiving one treatment or another. <br />For more information go to: <br />Province Place where the study consultation is carried out (sites already included) To contact <br />Havana Hospital October 10 <br />Ground floor of the Mella Pavilion in the Physiotherapy Room Monday-8:30 am-12:00 m <br />Dr. Yulmys Rodríguez Borges, Physiatry Consultation, <br />Dr. Abdel del Busto Mesa <br />Phone: 78776267, ext 261 <br />Pinar del Río Hospital Abel Santamaría 2nd and 4th Monday: Dr. Yusleny Sánchez Orta, Pulmonology <br />3rd Wednesday. Dr. Yoima González Pérez, Control Consultation 3, Hospital Abel Santamaría <br />Tuesday morning: Dra. Arlety Pita Valdés, Control Consultation 3, Hosp. Abel Santamaria <br />Phone 48 762068 <br />Cienfuegos Hospital Gustavo Aldereguía Lima, CEA Tuesday, 8:00 am-12:00 m <br />General evaluation consultation, every day <br />Consultation of the CIs: <br />Lic. Yuleidis García Rodríguez <br />Lic. Karelia Cortina Naples <br />Dr. Julio Jova Duenas <br />Dr. Annia Hernandez Marin <br />Phone: 43591751 <br />Villa Clara Hospital Arnaldo Milián Lic. Margarita Ríos Cabrera <br />Dr. Ignacio Ramirez Gomez <br />Phone: 42 270038 <br />Camaguey Manuel Ascunce Domenech Hospital, Clinical Trials Department (in the basement) Thursday- 9:00 am-12:00 pm <br />Lic. Judith Ojeda de Pedro <br />Lic. Yaneidys Lores Méndez <br />Dr. Yanara Nélida Peláez Guevara <br />Phone: 32 253856 <br />Holguin Vladimir Ilich Lenin Hospital, <br />EC Department 1st and 3rd Thursday of each month, 9:00 am <br />Lic. Kenya Garces Avila <br />Dr. Irmary Riverón Proenza <br />Phone: 24 461601 <br />Guantanamo Agostinho Neto Hospital <br />Clinical Trials Consultation Thursday- 1:00 pm-4:00 pm <br />Mr. Yadyleidis Elias Oquendo <br />Lic. Cecilia Sayoux Thaureaux <br />Dr. Anais González Jarrosay <br />Dr. Yanet Blanco Robles <br />Phone: 21 387319 <br />Santiago de Cuba Polyclinic of Specialties attached to the Saturnino Lora Hospital, Clinical Trials Consultation, 3rd Floor, Door 6 Friday, 9:00 am-12:00 m <br />Dr. Eduardo Rivero Rosales <br />Lic. Aymara Rosdo <br />Dr. Juan Carlos Sanchez Moraguez <br />Phone: 22 645447

download pdf




Phone Board:
General Direction:
15 Street and 216 Street, Siboney, Playa, La Habana, Cuba. A.P 16040, La Habana 11600, Cuba
Postal Code:
11 600
Post Office Box:
16 040

Frequent Questions

How can I access the therapeutic vaccines against lung cancer?

Cuba has 2 therapeutic vaccines for advanced lung cancer:
CIMAvax EGF ® and VAXIRA ® (racotumomab). Both therapeutic vaccines have sanitary registration in the indication of stage III and IV advanced non-small cell lung cancer (NSCLC), after the first line of chemotherapy. The main clinical benefit of these vaccines has been shown to be increased survival and improved quality of life, as well as a broad safety profile.

How to acquire the vaccines?
Foreigners should contact the Cuban Medical Services who will evaluate each case as part of a comprehensive patient care program, with commercial value.

-Cuban Medical Services. Web page:; E-mail:
Phone: (537) 209-0977 Fax: (537) 203-1590.

You can also make your request for care expressing the reason for your request, a medical summary and personal data directly to:

International Clinic of the Hermanos Ameijeiras Hospital.
Calle San Lázaro # 701 esq. to Belascoaín, Havana Center, Havana, C.P: 10400, Cuba.
Telephone: (537) 8761029, (537) 8761030, (537) 8761683. Email:

International Health Center
La Pradera Calle 15 between 222 A and 234, Siboney neighborhood, Playa Municipality, Havana, Cuba
Telephone: (+537) 273 7467 Ext. 403 (+537) 2737202. Email:

Mas preguntas frecuentes...


We ensure the quality, safety and effectiveness of our medicines.
We offer information on the use of our products to patients, families and professionals.
Your contribution is very important..
Report suspected adverse reactions here: